Results 171 to 180 of about 665,294 (217)

Role of <i>Brassica oleracea var. botrytis</i> (L.) as an aromatase inhibitor in Sprague-Dawley rats: Analysis of serum aromatase and testosterone. [PDF]

Open Vet J
Pratama JWA, Astuti P, Airin CM, Prakoso YA.   +3 more
europepmc   +1 more source

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]

BMC Musculoskelet Disord
Zhang Y, Cui W, Hou L.
europepmc   +1 more source

CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinoma. [PDF]

J Dtsch Dermatol Ges
Glatzel V, Tomsitz D, Maurer M, Schneider S, Brunner S, Harbeck N, Heinzerling L.   +6 more
europepmc   +1 more source

Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol. [PDF]

Integr Cancer Ther
Meyer H, Koppold DA, Shaker O, Eden L, Schiffmann L, Konigorski S, Cramer H, Choi KA, Einsele H, Winkler M, Löffler C.   +10 more
europepmc   +1 more source

Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study. [PDF]

ESMO Open
Valenza C, Etessami JD, Milano M, Papadopoulos N, Alvino M, Antonarelli G, Bianco N, Sangalli C, Trapani D, Pravettoni G, Omodeo Salè E, Passerini R, Colleoni M, Munzone E, Curigliano G.   +14 more
europepmc   +1 more source

Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice. [PDF]

Molecules
Taheri H, Ahmed E, Hu P, Sparreboom A, Hu S.   +4 more
europepmc   +1 more source

Aromatase Inhibitor-Related Lower Limb Tendinopathies: Ultrasound is on the Agenda. [PDF]

Eur J Breast Health
Yalçınkaya B, Çolak AF, Aksoy S, Kara M, Özçakar L.   +4 more
europepmc   +1 more source

Real-world effectiveness of palbociclib plus an aromatase inhibitor in HR+/HER2- MBC patients living in disadvantaged neighborhoods. [PDF]

NPJ Breast Cancer
Lynce F, Liu X, Li B, McRoy L, Chen C, Liu R, Rugo HS.   +6 more
europepmc   +1 more source

Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice. [PDF]

Breast
Rugo HS, Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Lynce F, Cottu P, Thill M, Curigliano G.   +11 more
europepmc   +1 more source

The experience of musculoskeletal symptoms among patients with breast cancer during aromatase inhibitor therapy: A qualitative study. [PDF]

Asia Pac J Oncol Nurs
Cao Y, Jing F, Jiang L, Tian M, Qiu J, Tang L, Hu Y.   +6 more
europepmc   +1 more source